1. Academic Validation
  2. Scaffold-Hopping Approach To Discover Potent, Selective, and Efficacious Inhibitors of NF-κB Inducing Kinase

Scaffold-Hopping Approach To Discover Potent, Selective, and Efficacious Inhibitors of NF-κB Inducing Kinase

  • J Med Chem. 2018 Aug 9;61(15):6801-6813. doi: 10.1021/acs.jmedchem.8b00678.
Nicole Blaquiere 1 Georgette M Castanedo 1 Jason D Burch 1 Leonid M Berezhkovskiy 1 Hans Brightbill 1 Suzanne Brown 1 Connie Chan 1 Po-Chang Chiang 1 James J Crawford 1 Teresa Dong 1 Peter Fan 1 Jianwen Feng 1 Nico Ghilardi 1 Robert Godemann 2 Emily Gogol 1 Alice Grabbe 2 Alison J Hole 2 Baihua Hu 3 Sarah G Hymowitz 1 Moulay Hicham Alaoui Ismaili 1 Hoa Le 1 Patrick Lee 1 Wyne Lee 1 Xingyu Lin 3 Ning Liu 1 Paul A McEwan 2 Brent McKenzie 1 Hernani L Silvestre 2 Eric Suto 1 Swathi Sujatha-Bhaskar 1 Guosheng Wu 3 Lawren C Wu 1 Yamin Zhang 3 Zoe Zhong 1 Steven T Staben 1
Affiliations

Affiliations

  • 1 Genentech, Inc. , 1 DNA Way , South San Francisco , California 94080 , United States.
  • 2 Evotec AG , Manfred Eigen Campus, Essener Bogen , Hamburg 22419 , Germany.
  • 3 Pharmaron Beijing Co., Ltd. , 6 Taihe Road, BDA , Beijing 100176 , P. R. China.
Abstract

NF-κB-inducing kinase (NIK) is a protein kinase central to the noncanonical NF-κB pathway downstream from multiple TNF Receptor family members, including BAFF, which has been associated with B cell survival and maturation, dendritic cell activation, secondary lymphoid organ development, and bone metabolism. We report herein the discovery of lead chemical series of NIK inhibitors that were identified through a scaffold-hopping strategy using structure-based design. Electronic and steric properties of lead compounds were modified to address glutathione conjugation and amide hydrolysis. These highly potent compounds exhibited selective inhibition of LTβR-dependent p52 translocation and transcription of NF-κB2 related genes. Compound 4f is shown to have a favorable pharmacokinetic profile across species and to inhibit BAFF-induced B cell survival in vitro and reduce splenic marginal zone B cells in vivo.

Figures
Products